Determination of genes and microRNAs involved in the resistance to fludarabine <it>in vivo </it>in chronic lymphocytic leukemia
<p>Abstract</p> <p>Background</p> <p>Chronic lymphocytic leukemia (CLL) cells are often affected by genomic aberrations targeting key regulatory genes. Although fludarabine is the standard first line therapy to treat CLL, only few data are available about the resistance...
Main Authors: | Muller Arnaud, Bernardin François, Leners Bernadette, Van Moer Kris, Aouali Nasséra, El Khoury Victoria, Wenner Thomas, Poirel Hélène A, Vallar Laurent, Palissot Valérie, Moussay Etienne, Cornillet-Lefebvre Pascale, Delmer Alain, Duhem Caroline, Ries Fernand, van Dyck Eric, Berchem Guy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/115 |
Similar Items
-
Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.
by: Nassera Aouali, et al.
Published: (2015-01-01) -
Paraneoplastic pemphigus - An association with fludarabine?
by: Littlewood, T, et al.
Published: (1998) -
Paraneoplastic pemphigus: an association with fludarabine?
by: Gooptu, C, et al.
Published: (2001) -
A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia
by: Steve Kong, et al.
Published: (2024-08-01) -
[18F]-Fludarabine for Hematological Malignancies
by: Louisa Barré, et al.
Published: (2019-04-01)